FundedIQ
Biotechnology

SAVA: Funding, Investors & Team (Oct 2026)

SAVA is revolutionizing the way individuals engage with their health by utilizing cutting-edge biosensing technology that can access internal health information quickly, efficiently, and without discomfort in real-time and at an accessible cost. This information is all located just below the surface of our skin.

sava.health LinkedIn London, United Kingdom 51-100 employees
Biotechnology Diabetes Fitness Health Care Medical Device Wearables Wellness B2C
Total raised
$8.0M
Rounds
1
Latest
Seed
Jun 2024

SAVA has raised $8.0M across 1 funding round on record, the most recent a Seed of $8.0M announced in Jun 2024.

That round is in line with the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

SAVA Company Profile and Key Stats

Total funding raised
$8.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$8.0M in Jun 2024
Employees
51-100
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Jun 2024.

SAVA Funding Rounds

Date
Round
Amount
Seed
$8.0M

SAVA Founders and Leadership Team

Name
Role
Contact
Rafael Michaeli
Founder
Locked
Rafael Michali
Founder
Locked

Contact details for the SAVA team: 2 of 2 have an email address on file.

Start 14-day free trial →

SAVA Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M
17,153
$3.1M

SAVA's latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like SAVA in Biotechnology and London

Companies Similar to SAVA

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

SAVA Funding FAQs

What does SAVA do?

SAVA is revolutionizing the way individuals engage with their health by utilizing cutting-edge biosensing technology that can access internal health information quickly, efficiently, and without discomfort in real-time and at an accessible cost. This information is all located just below the surface of our skin.

How much funding has SAVA raised?

SAVA has raised $8.0M across 1 round on record. The most recent is a Seed of $8.0M announced in Jun 2024.

When did SAVA last raise funding?

SAVA's most recent funding round on record is a Seed of $8.0M, announced in Jun 2024.

Who founded SAVA?

FundedIQ lists Rafael Michaeli (Founder), Rafael Michali (Founder) at SAVA.

Where is SAVA headquartered?

SAVA is based in London, England, United Kingdom.

How many employees does SAVA have?

SAVA is in the 51-100 employee band.

How does SAVA's funding compare to other Biotechnology startups?

SAVA's latest round of $8.0M is in line with the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's SAVA Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SAVA is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.